cabozantinib and saracatinib

cabozantinib has been researched along with saracatinib* in 1 studies

Other Studies

1 other study(ies) available for cabozantinib and saracatinib

Article	Year
Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells. Molecular cancer therapeutics, 2017, Volume: 16, Issue:11 Neurofibromatosis type 2 (NF2) is a nervous system tumor disorder caused by inactivation of the merlin tumor suppressor encoded by the Topics: Anilides; Animals; Apoptosis; Benzodioxoles; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Dasatinib; Humans; Mice; Neurilemmoma; Neurofibromin 2; Proto-Oncogene Proteins c-met; Pyridines; Quinazolines; Schwann Cells; src-Family Kinases; Xenograft Model Antitumor Assays	2017

Article

Year

Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells.

Molecular cancer therapeutics, 2017, Volume: 16, Issue:11

Neurofibromatosis type 2 (NF2) is a nervous system tumor disorder caused by inactivation of the merlin tumor suppressor encoded by the

Topics: Anilides; Animals; Apoptosis; Benzodioxoles; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Dasatinib; Humans; Mice; Neurilemmoma; Neurofibromin 2; Proto-Oncogene Proteins c-met; Pyridines; Quinazolines; Schwann Cells; src-Family Kinases; Xenograft Model Antitumor Assays

2017